Drug ID: | NPD3925 |
Drug Name: | |
Molecular Formula: | C20H21NO5 |
Canonical SMILES: | CC(CCOC(=O)c1cc(=O)c2c(o1)c1ccc(c(c1nc2O)C)C)C |
Standard InCHI: | InChI=1S/C20H21NO5/c1-10(2)7-8-25-20(24)15-9-14(22)16-18(26-15)13-6-5-11(3)12(4)17(13)21-19(16)23/h5-6,9-10H,7-8H2,1-4H3,(H,21,23) |
Standard InCHIKey: | NFQIAEMCQGTTIR-UHFFFAOYSA-N |
Max Developmental Stage: | Approved |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DIB004205 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | |
ChEBI | |
CAS Number |
Molecular Weight | 355.14 |
ALogP | 0.5255 |
MLogP | 3 |
XLogP | 4.118 |
HDA | 4 |
HBD | 1 |
Rotatable Bonds | 10 |
TPSA | 85.72 |
RO5 Violation | 0 |